Humanized Mouse And Rat Model Market Size Worth USD 2.1 billion Growing at a CAGR of 6.5%

NEW CITY, N.Y. - Jan. 18, 2023 - PRLog -- The growth of the market is due to a growing number of research activities using humanized animals, the demand for personalized medicine, a rising number of R&D activities at pharmaceutical and biotechnology companies, and continuous support from both the government sector and the private sector through grants and investments. This report is designed to describe, forecast, and analyze the Humanized Mouse and Rat Model Market size based on type and end-user.

The growing market for genetically engineered models is driving its growth. This model can help researchers validate and identify potential therapeutic targets. The market will be driven by increasing R&D spending in the pharmaceutical and biotechnology sectors. Market growth is driven primarily by demand for humanized ACE2 mice models (hACE2) that study the pathogenesis of SARS-CoV-2. Many major players are focused on developing models that support COVID-19 research.

Driving Factors

Driver: Growing demand to personalize medicine

Personalized medicine refers to developing tailored medicines that target specific treatment and care. These medicines are created using animal models, especially mice models. The disease is then recorded, and immune-deficient models are transplanted using human tissues. The model is then treated with various drugs and gene therapies to determine the best treatment. This allows for personalized medicine to be created for each patient.

Key Market Segments
Type

Genetic
Cell-Based
Application

Pharmaceutical
Biotechnology Companies

Key Market Players included in the report:

The  Jackson Laboratory (US)

Taconic Biosciences (US)

Horizon Discovery Group plc (UK)

genOway (France)

Charles River Laboratories (US)

Harbour Antibodies BV (China)

Hera   BioLabs (US)

Vitalstar Biotechnology Co (China)

inGenious Targeting Laboratory (US)

AXENIS S.A.S (France)

Crown Bioscience (US)

Transgenic (Japan)

Champions  Oncology (US)

Horizon Discovery Group plc (UK)

Hera  BioLabs (US)

Yecuris Corporation (US)

To know about more drivers and challenges - Download a PDF sample@ https://market.us/report/humanized-mouse-and-rat-model-market/request-sample/